Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Tumor Targeting With Antibody-Functionalized, Radiolabeled Carbon Nanotubes

M. McDevitt, D. Chattopadhyay, B. Kappel, J. S. Jaggi, Scott R. Schiffman, C. Antczak, J. T. Njardarson, R. Brentjens, D. Scheinberg
Published 2007 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Single-walled carbon nanotubes (CNT) are mechanically robust graphene cylinders with a high aspect ratio that are comprised of sp2-bonded carbon atoms and possessing highly regular structures with defined periodicity. CNT exhibit unique mechanochemical properties that can be exploited for the development of novel drug delivery platforms. We hypothesized that novel prototype nanostructures consisting of biologics, radionuclides, fluorochromes, and CNT could be synthesized and designed to target tumor cells. Methods: Tumor-targeting CNT constructs were synthesized from sidewall-functionalized, water-soluble CNT platforms by covalently attaching multiple copies of tumor-specific monoclonal antibodies, radiometal-ion chelates, and fluorescent probes. The constructs were characterized spectroscopically, chromatographically, and electrophoretically. The specific reactivity of these constructs was evaluated in vitro by flow cytometry and cell-based immunoreactivity assays and in vivo using biodistribution in a murine xenograft model of lymphoma. Results: A soluble, reactive CNT platform was used as the starting point to build multifunctional constructs with appended antibody, metal-ion chelate, and fluorescent chromophore moieties to effect specific targeting, to carry and deliver a radiometal-ion, and to report location, respectively. These nanoconstructs were found to be specifically reactive with the human cancer cells they were designed to target in vivo in a model of disseminated human lymphoma and in vitro by flow cytometry and cell-based immunoreactivity assays versus appropriate controls. Conclusion: The key achievement in these studies was the selective targeting of tumor in vitro and in vivo by the use of specific antibodies appended to a soluble, nanoscale CNT construct. The ability to specifically target tumor with prototype-radiolabeled or fluorescent-labeled, antibody-appended CNT constructs was encouraging and suggested further investigation of CNT as a novel delivery platform.
This paper references
Improved in vivo stability and tumor targeting of bismuth-labeled antibody.
C. Ruegg (1990)
Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics.
R. J. Kok (2002)
Synthesis and in vitro testing of J591 antibodydendrimer conjugates for targeted prostate cancer therapy
AK Patri (2004)
Peptide-amphiphile nanofibers: A versatile scaffold for the preparation of self-assembling materials
J. D. Hartgerink (2002)
Introduction to Carbon Materials Research
M. Dresselhaus (2001)
Toxic Potential of Materials at the Nanolevel
A. Nel (2006)
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies.
T. Nikula (1995)
Disseminated or localized growth of a human B‐cell tumor (Daudi) in scid mice
M. A. Ghetie (1990)
Second antibody clearance of radiolabeled antibody in cancer radioimmunodetection.
R. Sharkey (1984)
Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.
A. Bianco (2005)
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.
R. Singh (2006)
Complete elimination of metal catalysts from single wall carbon nanotubes
D. Chattopadhyay (2002)
Amino acid functionalisation of water soluble carbon nanotubes.
V. Georgakilas (2002)
Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2.
B. Müller (1990)
Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells
Jean-Baptiste Latouche (2000)
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
I. Majoros (2006)
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies
D. Ma (2002)
Impact of the high tyrosine fraction in complementary determining regions: measured and predicted effects of radioiodination on IgG radioimmunotherapy
TK Nikula (1995)
Biodistribution of carbon single-wall carbon nanotubes in mice.
H. Wang (2004)
Tissue sulfhydryl groups.
G. Ellman (1959)
Vaccine delivery by carbon nanotubes.
M. in het Panhuis (2003)
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
I. Rivière (1995)
Design and synthesis of 225Ac radioimmunopharmaceuticals.
M. McDevitt (2002)
Translocation of bioactive peptides across cell membranes by carbon nanotubes.
D. Pantarotto (2004)
Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells
A. Shvedova (2003)
Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity.
T. Nikula (1995)
Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction.
N. W. Kam (2005)
Preparation and Functional Evaluation of RGD-Modified Proteins as r v â 3 Integrin Directed Therapeutics
R. J. Kok
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
K. Hamblett (2004)
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction.
V. Sarin (1981)
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.
M. Mammen (1998)
Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells.
H. Dumortier (2006)
V Georgakilas (2002)
CCR2 is required for CD8-induced graft-versus-host disease.
T. Terwey (2005)
Biodistribution of carbon single-wall nanotubes in mice
H Wang (2004)
Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells.
P. Cherukuri (2004)
Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into Mammalian cells.
Nadine Wong Shi Kam (2004)
Double functionalization of carbon nanotubes for multimodal drug delivery.
Giorgia Pastorin (2006)
Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro.
C. Sayes (2006)
Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand-protein conjugates.
E. Dadachova (1999)
Tumor Therapy with Targeted Atomic Nanogenerators
M. McDevitt (2001)
New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.
J. M. Esteban (1987)
HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.
R. Shukla (2006)
Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging.
V. S. Talanov (2006)
Design and synthesis of 225 Ac radioimmunopharmaceuticals
Mr Mcdevitt (2002)
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.
A. Patri (2004)

This paper is referenced by
Nanoparticles in Nuclear Imaging
Vicky V. Mody (2011)
Emerging role of radiolabeled nanoparticles as an effective diagnostic technique
AndréLuís Branco de Barros (2012)
Improving immunosensor performance through oriented immobilization of antibodies on carbon nanotube composite surfaces.
S. Puertas (2013)
Carbon nanotubes in nanomedicine
R. ElSayed (2016)
Synthesis, characterization and cytotoxicity evaluation of carboxylated carbon nanotubes functionalized with silibinin, betulinic acid and levodopa for drug delivery
J. Tan (2015)
Radionuclide therapy using 131I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression
W. Li (2015)
Functionalised carbon nanotubes: high biocompatibility with lack of toxicity
M. Herrero (2011)
Applications of Functionalized Carbon Nanotubes for the Therapy and Diagnosis of Cancer
Yongsung Hwang (2017)
Pharmacokinetics, Metabolism and Toxicity of Carbon Nanotubes for Biomedical Purposes
Sheng-Tao Yang (2012)
Zoran S. Markovi (2010)
Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.
A. Tan (2011)
Analytical strategies for real-time, non-invasive tracking of carbon nanomaterials in vivo
Aijuan Liu (2013)
An overview of nanoparticle biocompatibility for their use in Nanomedicine
Matthew S. P. Boyles (2017)
Carbon Nanotube Degradation in Macrophages: Live Nanoscale Monitoring and Understanding of Biological Pathway.
D. Elgrabli (2015)
Carbon nanotubes for delivery of small molecule drugs.
B. Wong (2013)
Radioimmunotherapy-based treatment of cancer
S. Farrokhi (2012)
Raman spectroscopy as a detection and analysis tool for in vitro specific targeting of pancreatic cancer cells by EGF‐conjugated, single‐walled carbon nanotubes
Alokita Karmakar (2012)
In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes.
H. K. Moon (2009)
Encapsulated gadolinium and dysprosium ions within ultra-short carbon nanotubes for MR microscopy at 11.75 and 21.1 T.
J. Rosenberg (2014)
Biodistribution and Pharmacokinetics of Carbon Nanomaterials In Vivo
Sheng-Tao Yang (2016)
Carbon Nanotubes as an Effective Opportunity for Cancer Diagnosis and Treatment
A. Sanginario (2017)
Characterization and in vitro sustained release of silibinin from pH responsive carbon nanotube-based drug delivery system
J. Tan (2014)
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
M. Makvandi (2018)
Carbon nanotubes: a novel material for multifaceted applications in human healthcare.
S. Kumar (2017)
Functionalized carbon nanotubes in bio-world: Applications, limitations and future directions
Sireesha Merum (2017)
Applications of Carbon Nanotubes in Oncology
V. Yurgel (2013)
A Systematic Framework and Nanoperiodic Concept for Unifying Nanoscience: Hard/Soft Nanoelements, Superatoms, Meta-Atoms, New Emerging Properties, Periodic Property Patterns, and Predictive Mendeleev-like Nanoperiodic Tables.
D. Tomalia (2016)
Layered double hydroxide nanoparticles for biomedical applications: Current status and recent prospects
Yaswanth Kuthati (2015)
Towards an integrated medical imaging-sensing-therapeutic platform using electromagnetically-controlled nanomachines: a preliminary conceptual design
Y. Chen (2011)
Title PET-MR and SPECT-MR multimodality probes : development and challenges
Chang-Tong Yang (2019)
Nanotargeted Radiopharmaceuticals for Nuclear Imaging and Radiotherapy
G. Ting (2014)
Advance in Research on Carbon Nanotubes as Diagnostic and Therapeutic Agents for Tumor
Shaoyu Cai (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar